These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 29183843)

  • 1. The Montreal Cognitive Assessment-Basic (MoCA-B) is not a reliable screening tool for cognitive decline in HIV patients receiving combination antiretroviral therapy in rural South Africa.
    Hakkers CS; Beunders AJM; Ensing MHM; Barth RE; Boelema S; Devillé WLJ; Tempelman HA; Coutinho RA; Hoepelman AIM; Arends JE; van Zandvoort MJE
    Int J Infect Dis; 2018 Feb; 67():36-40. PubMed ID: 29183843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
    Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
    BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric utility of the international HIV dementia scale and Montreal Cognitive Assessment in HIV-associated asymptomatic neurocognitive impairment.
    Aita SL; Kaewpoowat Q; Yasri S; Rerkasem A; Rerkasem K; Choovuthayakorn J; Ausayakhun S; Robertson K; Roth RM; Robbins NM
    J Neurovirol; 2021 Aug; 27(4):568-578. PubMed ID: 34185242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment and neurocognitive profiles among people living with HIV and HIV-negative individuals older over 50 years: a comparison of IHDS, MMSE and MoCA.
    Chen P; Xin X; Xiao S; Liu H; Liu X; He N; Ding Y
    J Neurovirol; 2024 Apr; 30(2):103-114. PubMed ID: 38709469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
    Fazeli PL; Casaletto KB; Paolillo E; Moore RC; Moore DJ; The Hnrp Group
    J Clin Exp Neuropsychol; 2017 Nov; 39(9):842-853. PubMed ID: 28122474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive evaluation using the International HIV Dementia Scale (IHDS) and Montreal Cognitive Assessment Test (MoCA) in an HIV-2 population.
    Almeida F; Macedo A; Trigo D; Abreu M; Guimarães M; Luís N; Pinho R; Tavares R
    HIV Med; 2021 Mar; 22(3):212-217. PubMed ID: 33012065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional deficits and other psychiatric associations with abnormal scores on the Montreal Cognitive Assessment (MoCA) in older HIV-infected patients.
    Bourgeois JA; John M; Zepf R; Greene M; Frankel S; Hessol NA
    Int Psychogeriatr; 2020 Jan; 32(1):105-118. PubMed ID: 31014404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Using the Montreal Cognitive Assessment (MoCA) as a Screening Tool for HIV-Associated Neurocognitive Disorders (HAND) In Multi-Ethnic Malaysia.
    Mukherjee T; Sakthivel R; Fong HY; McStea M; Chong ML; Omar SF; Chin AV; Kamaruzzaman S; Kamarulzaman A; Rajasuriar R; Cysique LA
    AIDS Behav; 2018 Oct; 22(10):3226-3233. PubMed ID: 29508103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa.
    Joska JA; Witten J; Thomas KG; Robertson C; Casson-Crook M; Roosa H; Creighton J; Lyons J; McArthur J; Sacktor NC
    AIDS Behav; 2016 Aug; 20(8):1621-31. PubMed ID: 26860536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the Montreal Cognitive Assessment (MoCA) and its subset in HIV-associated neurocognitive disorder (HAND) screening.
    Kim WJ; Ku NS; Lee YJ; Ahn JY; Kim SB; Ahn HW; Hong KW; Song JY; Cheong HJ; Kim WJ; Kim JM; Namkoong K; Choi JY; Kim E
    J Psychosom Res; 2016 Jan; 80():53-7. PubMed ID: 26721548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive Impairment in a Chronically Well-Suppressed HIV-Infected Population: The Dutch TREVI Cohort Study.
    van den Dries LWJ; Wagener MN; Jiskoot LC; Visser M; Robertson KR; Adriani KS; van Gorp ECM
    AIDS Patient Care STDS; 2017 Aug; 31(8):329-334. PubMed ID: 28753395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of the International HIV Dementia Scale in South Africa.
    Joska JA; Westgarth-Taylor J; Hoare J; Thomas KG; Paul R; Myer L; Stein DJ
    AIDS Patient Care STDS; 2011 Feb; 25(2):95-101. PubMed ID: 21214343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation.
    Phillips NJ; Thomas KGF; Myer L; Sacktor N; Zar HJ; Stein DJ; Hoare J
    AIDS; 2019 Apr; 33(5):815-824. PubMed ID: 30649059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients.
    Janssen MA; Bosch M; Koopmans PP; Kessels RP
    J Neurovirol; 2015 Aug; 21(4):383-90. PubMed ID: 25678141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
    Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
    AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE).
    Milanini B; Ciccarelli N; Fabbiani M; Baldonero E; Limiti S; Gagliardini R; Borghetti A; D'Avino A; Mondi A; Colafigli M; Cauda R; Di Giambenedetto S
    Clin Neuropsychol; 2016; 30(sup1):1457-1468. PubMed ID: 27180611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: major and mild neurocognitive disorders.
    Liew TM; Feng L; Gao Q; Ng TP; Yap P
    J Am Med Dir Assoc; 2015 Feb; 16(2):144-8. PubMed ID: 25282632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Montreal Cognitive Assessment: A Pilot Study of a Brief Screening Tool for Mild and Moderate Cognitive Impairment in HIV-Positive Veterans.
    Chartier M; Crouch PC; Tullis V; Catella S; Frawley E; Filanosky C; Carmody T; McQuaid J; Lampiris H; Wong JK
    J Int Assoc Provid AIDS Care; 2015; 14(3):197-201. PubMed ID: 25487428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for HIV-associated dementia in South Africa: potentials and pitfalls of task-shifting.
    Robbins RN; Remien RH; Mellins CA; Joska JA; Stein DJ
    AIDS Patient Care STDS; 2011 Oct; 25(10):587-93. PubMed ID: 21919734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV and Cognitive Impairment in Clinical Practice: The Evaluation of a Stepwise Screening Protocol in Relation to Clinical Outcomes and Management.
    Hakkers CS; Kraaijenhof JM; van Oers-Hazelzet EB; Visser-Meily AJMA; Hoepelman AIM; Arends JE; Barth RE
    AIDS Patient Care STDS; 2017 Sep; 31(9):363-369. PubMed ID: 28783374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.